Demant Sustainability Profile
Demant A/S, commonly known as Demant, is a leading global player in the hearing healthcare and personal communication industry, headquartered in Denmark (DK). Founded in 1904, the company has evolved significantly, marking key milestones such as the introduction of innovative hearing aids and advanced audiometric equipment. Demant operates extensively across Europe, North America, and Asia, focusing on hearing aids, audiometric instruments, and personal communication solutions. Their core products, renowned for their cutting-edge technology and user-centric design, set them apart in a competitive market. With a strong commitment to research and development, Demant has established itself as a trusted name, achieving notable recognition for its contributions to improving the quality of life for individuals with hearing loss.
DitchCarbon Score
How does Demant's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Demant's score of 81 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Demant's reported carbon emissions
In 2024, Demant reported total carbon emissions of approximately 493,529,000 kg CO2e, comprising 14,645,000 kg CO2e from Scope 1, 14,781,000 kg CO2e from Scope 2, and a significant 464,103,000 kg CO2e from Scope 3 emissions. This marks a decrease from 2023, where total emissions were about 525,129,000 kg CO2e, with Scope 1 at 12,316,000 kg CO2e, Scope 2 at 18,153,000 kg CO2e, and Scope 3 at 793,306,000 kg CO2e. Demant has set ambitious climate commitments, aiming for a minimum 50% reduction in Scope 1 and 2 emissions by 2030, using 2019 as a baseline. Additionally, they target a 46.2% reduction in Scope 3 emissions within the same timeframe. Long-term goals include a 90% reduction in both Scope 1 and 2 emissions by 2050, alongside a similar target for Scope 3 emissions. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Demant's commitment to achieving net-zero greenhouse gas emissions across its value chain by 2050. The company is actively working towards these goals, demonstrating a strong commitment to sustainability and climate action within the healthcare technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 4,368,000 | - | 00,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 19,897,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Demant's Industry?
How Carbon Intensive is Demant's Location?
Demant's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Demant has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Amplifon
Frequently Asked Questions
Common questions about Demant's sustainability data and climate commitments